Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Discovery of novel histidine-derived lipo-amino acids: applied in the synthesis of ultra-short antimicrobial peptidomimetics having potent antimicrobial activity, salt resistance and protease stability.

Ahn M, Murugan RN, Jacob B, Hyun JK, Cheong C, Hwang E, Park HN, Seo JH, Srinivasrao G, Lee KS, Shin SY, Bang JK.

Eur J Med Chem. 2013 Oct;68:10-8. doi: 10.1016/j.ejmech.2013.07.008.

PMID:
23933046
2.

Synthesis of short cationic antimicrobial peptidomimetics containing arginine analogues.

Baldassarre L, Pinnen F, Cornacchia C, Fornasari E, Cellini L, Baffoni M, Cacciatore I.

J Pept Sci. 2012 Sep;18(9):567-78. doi: 10.1002/psc.2435.

PMID:
22807132
3.

Lipo-γ-AApeptides as a new class of potent and broad-spectrum antimicrobial agents.

Niu Y, Padhee S, Wu H, Bai G, Qiao Q, Hu Y, Harrington L, Burda WN, Shaw LN, Cao C, Cai J.

J Med Chem. 2012 Apr 26;55(8):4003-9. doi: 10.1021/jm300274p.

PMID:
22475244
4.

Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents.

Murugan RN, Jacob B, Kim EH, Ahn M, Sohn H, Seo JH, Cheong C, Hyun JK, Lee KS, Shin SY, Bang JK.

Bioorg Med Chem Lett. 2013 Aug 15;23(16):4633-6. doi: 10.1016/j.bmcl.2013.06.016.

PMID:
23816372
5.

Poly-lysine peptidomimetics having potent antimicrobial activity without hemolytic activity.

Ahn M, Jacob B, Gunasekaran P, Murugan RN, Ryu EK, Lee GH, Hyun JK, Cheong C, Kim NH, Shin SY, Bang JK.

Amino Acids. 2014 Sep;46(9):2259-69. doi: 10.1007/s00726-014-1778-z.

PMID:
24961649
6.

Non-hemolytic α-AApeptides as antimicrobial peptidomimetics.

Padhee S, Hu Y, Niu Y, Bai G, Wu H, Costanza F, West L, Harrington L, Shaw LN, Cao C, Cai J.

Chem Commun (Camb). 2011 Sep 14;47(34):9729-31. doi: 10.1039/c1cc13684d.

PMID:
21779608
7.

De novo design and synthesis of ultra-short peptidomimetic antibiotics having dual antimicrobial and anti-inflammatory activities.

Murugan RN, Jacob B, Ahn M, Hwang E, Sohn H, Park HN, Lee E, Seo JH, Cheong C, Nam KY, Hyun JK, Jeong KW, Kim Y, Shin SY, Bang JK.

PLoS One. 2013 Nov 26;8(11):e80025. doi: 10.1371/journal.pone.0080025.

8.

Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones.

Jahnsen RD, Frimodt-Møller N, Franzyk H.

J Med Chem. 2012 Aug 23;55(16):7253-61. doi: 10.1021/jm300820a.

PMID:
22809409
9.

Short antimicrobial lipo-α/γ-AA hybrid peptides.

Li Y, Smith C, Wu H, Teng P, Shi Y, Padhee S, Jones T, Nguyen AM, Cao C, Yin H, Cai J.

Chembiochem. 2014 Oct 13;15(15):2275-80. doi: 10.1002/cbic.201402264.

10.

The development of antimicrobial a-AApeptides that suppress proinflammatory immune responses.

Padhee S, Smith C, Wu H, Li Y, Manoj N, Qiao Q, Khan Z, Cao C, Yin H, Cai J.

Chembiochem. 2014 Mar 21;15(5):688-94.

11.

Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.

Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY.

Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.

PMID:
24211081
12.

Synthetically modified L-histidine-rich peptidomimetics exhibit potent activity against Cryptococcus neoformans.

Mahindra A, Bagra N, Wangoo N, Jain R, Khan SI, Jacob MR, Jain R.

Bioorg Med Chem Lett. 2014 Jul 15;24(14):3150-4. doi: 10.1016/j.bmcl.2014.04.120.

13.

Systematic study of non-natural short cationic lipopeptides as novel broad-spectrum antimicrobial agents.

Lohan S, Cameotra SS, Bisht GS.

Chem Biol Drug Des. 2013 Nov;82(5):557-66. doi: 10.1111/cbdd.12182.

PMID:
23819506
14.

Development of novel membrane active lipidated peptidomimetics active against drug resistant clinical isolates.

Lohan S, Kalanta A, Sonkusre P, Cameotra SS, Bisht GS.

Bioorg Med Chem. 2014 Sep 1;22(17):4544-52. doi: 10.1016/j.bmc.2014.07.041.

PMID:
25131957
15.

The effect of an adding histidine on biological activity and stability of Pc-pis from Pseudosciaena crocea.

Mao Y, Niu S, Xu X, Wang J, Su Y, Wu Y, Zhong S.

PLoS One. 2013 Dec 13;8(12):e83268. doi: 10.1371/journal.pone.0083268.

16.

Antimicrobial activity of small beta-peptidomimetics based on the pharmacophore model of short cationic antimicrobial peptides.

Hansen T, Alst T, Havelkova M, Strøm MB.

J Med Chem. 2010 Jan 28;53(2):595-606. doi: 10.1021/jm901052r.

PMID:
19994905
17.

Antimicrobial benzodiazepine-based short cationic peptidomimetics.

Zats GM, Kovaliov M, Albeck A, Shatzmiller S.

J Pept Sci. 2015 Jun;21(6):512-9. doi: 10.1002/psc.2771.

PMID:
25807936
18.

Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.

Jahnsen RD, Sandberg-Schaal A, Vissing KJ, Nielsen HM, Frimodt-Møller N, Franzyk H.

J Med Chem. 2014 Apr 10;57(7):2864-73. doi: 10.1021/jm401335p.

PMID:
24601601
19.

Recent development of small antimicrobial peptidomimetics.

Niu Y, Wang RE, Wu H, Cai J.

Future Med Chem. 2012 Sep;4(14):1853-62. doi: 10.4155/fmc.12.111. Review.

PMID:
23043481
20.

Discovery of Trp-His and His-Arg analogues as new structural classes of short antimicrobial peptides.

Sharma RK, Reddy RP, Tegge W, Jain R.

J Med Chem. 2009 Dec 10;52(23):7421-31. doi: 10.1021/jm900622d.

PMID:
19655779

Supplemental Content

Support Center